Live Breaking News & Updates on Welfare Sciences Research

Stay updated with breaking news from Welfare sciences research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

A novel blood serum assay to diagnose neurode

Clusters of abnormally folded α-synuclein proteins, called seeds, trigger the formation of larger aggregates, leading to neurodegenerative disorders known as synucleinopathies. Researchers from Japan have developed a novel assay that can detect α-synuclein seeds in the blood. This new assay is highly sensitive, simple, quick, and can differentiate between synucleinopathies based on structural differences of the amplified seeds. This research was supported by the National Research Program for Neurological Disorders and Mental Health of the Japan Agency for Medical Research and Development (AMED). ....

Bunkyo Ku , Deborah Mcintyre , Daisuke Taniguchi , Michel Mittelbronn , Haruka Kimura , Taiji Tsunemi , Soichiro Kakuta , Nobutaka Hattori , Akihide Kondo , Ayami Okuzumi , Yoko Imamichi , Nobuyuki Nukina , Shinji Saiki , Shuko Nojiri , Taku Hatano , Takeshi Fukuhara , Manabu Funayama , Gen Matsumoto , Yasuo Uchiyama , Development Grants For Dementia , Welfare Sciences Research , Centre Hospitalier De Luxemburg , Technology Innovation Center , Ministry Of Education , Research On Policy Planning , Nagasaki University School Of Medicine ,

Eisai: Fully Human Anti-TNFalpha Monoclonal Antibody HUMIRA Obtains Additional Approval

Eisai: Fully Human Anti-TNFalpha Monoclonal Antibody HUMIRA Obtains Additional Approval
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Pediatr Gastroenterol Nutr , Eisai Group , Abbvie Gk Eisai Co Ltd , Ajinomoto Group , Colitis Association , Ea Pharma Co Ltd , Eisai Co Ltd , Public Affairs , Welfare Sciences Research , Public Relations Department , High Dose Regimen , Ulcerative Colitis , Adult Patients , New Regimen , Monoclonal Antibody , Subcutaneous Injection , Fully Human , Allergan Aesthetics , Australian Crohn , Economic Costs ,